HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Accepted manuscript (PDF) All Versions of this Article: EJE-08-0289v1 159/3/197    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Gooren, L. Articles by Mueller, A. PubMed PubMed Citation Articles by Gooren, L. Articles by Mueller, A.

HORMONE-RELATED TUMORS IN TRANSSEXUALS RECEIVING TREATMENT WITH CROSS-SEX HORMONES

L Gooren, Endocrinology , VUmc, Amsterdam , 1081HV, Netherlands
A Mueller, Department of Obstetrics and Gynecology, Erlangen University Hospital, Erlangen, Germany

Correspondence: Louis Gooren, Email: louisjgooren{at}gmail.com

Abstract

Objective: to assess the risks of development of hormone-related tumours in transsexuals receiving treatment with cross-sex hormones

Design: description of cases of transsexuals who have developed a hormone-related malignancy observed in the own clinic or reported in the literature. Recommendations for early diagnosis and prevention are presented.

Methods. Review of the literature in Pubmed.

Results: in male-to-female transsexuals receiving estrogen administration lactotroph adenomas, breast cancer and prostate cancer have been reported. In female-to-male transsexuals receiving treatment with testosterone a single case of breast carcinoma and several cases of ovarian cancer have been reported. So far endometrial cancer has not been encountered though it remains a potential malignant development.

Conclusions: there are so far only a few cases of hormone-related cancer in transsexuals. There may be an underreporting. The probability of a hormone-related tumor increases with duration of exposure to cross-sex hormones and the aging of the population of transsexuals